These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25579432)

  • 21. Advances in nucleoside monophosphate prodrugs as anti-HCV agents.
    Bobeck DR; Schinazi RF; Coats SJ
    Antivir Ther; 2010; 15(7):935-50. PubMed ID: 21041908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research of oral prodrugs: opportunities and challenges].
    Cao F; Ping QN; Chen J
    Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonate prodrugs.
    Vepsäläinen JJ
    Curr Med Chem; 2002 Jun; 9(12):1201-8. PubMed ID: 12052172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of salicylate ester prodrugs of cyclic HPMPC in dogs.
    Oliyai R; Arimilli MN; Jones RJ; Lee WA
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1411-4. PubMed ID: 11563033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist.
    Beaumont K; Webster R; Gardner I; Dack K
    Curr Drug Metab; 2003 Dec; 4(6):461-85. PubMed ID: 14683475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prodrug design targeting intestinal PepT1 for improved oral absorption: design and performance.
    Zhang Y; Sun J; Sun Y; Wang Y; He Z
    Curr Drug Metab; 2013 Jul; 14(6):675-87. PubMed ID: 23869811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AS-924, a novel, orally active, bifunctional prodrug of ceftizoxime: physicochemical properties, oral absorption in animals, and antibacterial activity.
    Mori N; Kodama T; Sakai A; Suzuki T; Sugihara T; Yamaguchi S; Nishijima T; Aoki A; Toriya M; Kasai M; Hatano S; Kitagawa M; Yoshimi A; Nishimura K
    Int J Antimicrob Agents; 2001 Nov; 18(5):451-61. PubMed ID: 11711261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs.
    Shaw JP; Sueoko CM; Oliyai R; Lee WA; Arimilli MN; Kim CU; Cundy KC
    Pharm Res; 1997 Dec; 14(12):1824-9. PubMed ID: 9453075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral delivery of anticancer drugs II: the prodrug strategy.
    Mazzaferro S; Bouchemal K; Ponchel G
    Drug Discov Today; 2013 Jan; 18(1-2):93-8. PubMed ID: 22960308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa.
    Yoshigae Y; Imai T; Aso T; Otagiri M
    Life Sci; 1998; 62(14):1231-41. PubMed ID: 9570338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macromolecular prodrugs. XV. Colon-targeted delivery--bioavailability of naproxen from orally administered dextran-naproxen ester prodrugs varying in molecular size in the pig.
    Harboe E; Larsen C; Johansen M; Olesen HP
    Pharm Res; 1989 Nov; 6(11):919-23. PubMed ID: 2480587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
    Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
    Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral delivery of peptide drugs: barriers and developments.
    Hamman JH; Enslin GM; Kotzé AF
    BioDrugs; 2005; 19(3):165-77. PubMed ID: 15984901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prodrug strategies for antihypertensives.
    Dhaneshwar SS; Sharma M; Patel V; Desai U; Bhojak J
    Curr Top Med Chem; 2011; 11(18):2299-317. PubMed ID: 21671866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats.
    Choi JS; Shin SC
    Int J Pharm; 2005 Mar; 292(1-2):149-56. PubMed ID: 15725561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current prodrug design for drug discovery.
    Hsieh PW; Hung CF; Fang JY
    Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability.
    Benzaria S; Pélicano H; Johnson R; Maury G; Imbach JL; Aubertin AM; Obert G; Gosselin G
    J Med Chem; 1996 Dec; 39(25):4958-65. PubMed ID: 8960556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zanamivir Amidoxime- and N-Hydroxyguanidine-Based Prodrug Approaches to Tackle Poor Oral Bioavailability.
    Schade D; Kotthaus J; Riebling L; Kotthaus J; Müller-Fielitz H; Raasch W; Hoffmann A; Schmidtke M; Clement B
    J Pharm Sci; 2015 Sep; 104(9):3208-19. PubMed ID: 26037932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition and oral bioavailability in rats of an antiviral and antitumor amino acid phosphoramidate prodrug of AZT-monophosphate.
    Song H; Johns R; Griesgraber GW; Wagner CR; Zimmerman CL
    Pharm Res; 2003 Mar; 20(3):448-51. PubMed ID: 12669967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dipeptidyl-peptidase IV (DPP IV/CD26)-activated prodrugs: a successful strategy for improving water solubility and oral bioavailability.
    Velázquez S; de Castro S; Diez-Torrubia A; Balzarini J; Camarasa MJ
    Curr Med Chem; 2015; 22(8):1041-54. PubMed ID: 25620096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.